NeuroVigil’s iBrain™ in TIME’s “Best Inventions of 2025”
iBrain™ - Copyright © 2025 NeuroVigil, Inc. All Rights Reserved. iBrain™ prototype iBrain™ with two quarters - Copyright © 2025...
Autism
Dartmouth’s play2Prevent Lab and Nonprofit Proof Positive Collaborate to Design Mental Health Games for Autistic Youth
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The play2PREVENT (p2P) Lab at the Geisel School of Medicine at Dartmouth has...
bobo, the AI-Driven Parenting Intelligence Platform, Launches in the United States
Revolutionary technology empowers parents with advanced insights about their children's development, transforming reactive pediatric care into proactive health monitoring WINNIPEG,...
Hipp Health Raises $6.2 Million in Seed Funding
Company Will Utilize Funds for Product Expansion, AI Investments, and Team GrowthSAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Hipp...
Stride Autism Centers Named a Winner of the 2025 Iowa Top Workplaces Award
DES MOINES, Iowa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early intervention ABA...
Brain Balance Onboards with ProsperityEHR to Strengthen Care for ADHD, Autism, and Learning Challenges
Partnership equips Brain Balance to scale its national network with a unified EHR that integrates clinical, financial, and operational workflows,...
EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation
Innovator of HD-EEG releases world’s most advanced EEG brain monitoring technology for neuroscience research EGI GES 500 Next-Generation HD-EEG Platform...
APhA alarmed by claims of harm from acetaminophen without substantive science
WASHINGTON, Sept. 23, 2025 /PRNewswire/ -- As the medication experts, APhA affirms there has been no new evidence in two...
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
Study led by CureShankAims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system...
iCare ABA Therapy Launches With AI-Supported Model, Sparks Industry Debate on AI’s Role in Autism Care
New York, NY, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The soft launch of iCare ABA Therapy is drawing attention across...
Linus Health’s AI-Driven Voice Analysis Technology Recognized in Gartner® Hype Cycle™ for Digital Care Delivery, 2025
BOSTON, Sept. 17, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and...
Imagine Pediatrics Raises $67M to Expand Access to Value-Based Care for Children with Special Health Care Needs
Funding to scale virtual and in-home care, enhance clinical innovation, and support vulnerable pediatric populations nationwide. Round includes continued support...
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),...
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),...
Action Behavior Centers Partners with El Paso Chihuahuas for Autism Awareness Night
EL PASO, TX / ACCESS Newswire / September 13, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based...
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
BOSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology,...
Dr. Robert Melillo and ‘A Moment of Xen’ join forces to bring ‘Brain-Based Wellness’ to National Radio, Digital Streaming TV, and social platforms
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media...
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives...
Action Behavior Centers Expands ABC Academy With Eight New Locations to Support School-Age Children with Autism
Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum...